Price movement over the last 24 hours
Alcon AG vs Harmony Gold Mining Co. — how do they compare? Alcon AG trades at $66.81 (market cap $32.69B), while Harmony Gold Mining Co. trades at $14.46 (market cap $9.60B). The key difference: Alcon AG is far larger — about 3.4× Harmony Gold Mining Co.'s market cap, and Harmony Gold Mining Co. pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| ALC | HMY | |
|---|---|---|
Market Cap | $32.69B | $9.60B |
Sector | Health | Basic Materials |
52-Week High | $92.22 | $26.04 |
52-Week Low | $62.02 | $12.61 |
Enterprise Value | $36.28B | $9.93B |
Dividend Yield | 0.54% | 2.65% |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Harmony Gold Mining (HMY) trades at $15.385, down 4.38% amid broader gold sector weakness. The stock shows strong fundamentals with 2024 revenue of $61.38B and net income of $8.59B, representing a 13.99% margin. Technical indicators signal bearish momentum with RSI at oversold levels. Recent earnings beat expectations in Q2 2025 but missed in Q4 2025, while analysts maintain a cautious stance with 70% hold ratings.
HMY presents value with attractive valuation ratios (P/E 10.42, EV/EBITDA 5.36) and robust profitability (ROE 32.32%). However, Fed rate hike concerns and gold price volatility pose near-term headwinds. The company's transition to gold-copper hybrid operations by 2028 offers long-term growth potential, though execution risks and commodity price exposure remain key considerations for investors.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →